Monoclonal Antibody
Atezolizumab Cas 1380723-44-3 C6446H9902N1706O1998S42
Atezolizumab Cas 1380723-44-3 C6446H9902N1706O1998S42 Chemical Information Product name:Atezolizumab Purity:95% min CAS NO:1380723-44-3 Solubility:Soluble in DMSO Molecular Formula:C6446H9902N1706O1998S42 Package:Package according to customer requirements Molecular Weight:144,612.59 g/mol Storage:Store at -20℃ Quality control COA Remarks Atezolizumab blocks the interaction of PD-L1 with programmed cell death protein 1 (PD-1) and CD80 receptors (B7-1Rs). PD-L1 can be highly
Chimeric Monoclonal Antibodies Infliximab Cas 170277-31-3
Chimeric Monoclonal Antibodies Infliximab Cas 170277-31-3 Chemical Information Product name:Infliximab Purity:95% min CAS NO:170277-31-3 Solubility:DMSO : ≥ 15.32mg/mL Molecular Formula:C6428H9912N1694O1987S46 Package:Package according to customer requirements Molecular Weight:144190.3 g/mol Storage:Store at -20℃ Quality control COA Remarks Infliximab is a chimeric monoclonal antibody biologic drug that works against tumor necrosis factor alpha (TNF-α) and is used to treat
Cas 946414-94-4 Nivolumab Monoclonal Antibodies For Breast Cancer
Cas 946414-94-4 Nivolumab Monoclonal Antibodies For Breast Cancer Chemical Information Product name:Nivolumab Purity:99% min CAS NO:946414-94-4 Solubility:Soluble in DMSO Molecular Formula:C6362H9862N1712O1995S42 Package:Package according to customer requirements Molecular Weight:143.6 kg/mol Storage:Store at -20℃ Quality control COA Remarks Nivolumab is a medication used to treat cancer. It is used as a first line treatment for inoperable or metastatic melanoma in combinatio
Cas 174722-31-7 rituximab monoclonal For Non Hodgkin'S Lymphoma
Cas 174722-31-7 rituximab monoclonal For Non Hodgkin'S Lymphoma Chemical Information Product name:Rituximab Purity:99% min CAS NO:174722-31-7 Solubility:Soluble in DMSO Molecular Formula:C6416H9874N1688O1987S44 Package:Package according to customer requirements Molecular Weight:143859.7 g/mol Storage:Store at -20℃ Quality control COA Remarks Rituximab is a medication used to treat certain autoimmune diseases and types of cancer.It is used for non-Hodgkin's lymphoma, chronic
High Affinity VEGF Bevacizumab Avastin Cas 216974-75-3
High Affinity VEGF Bevacizumab Avastin Cas 216974-75-3 Chemical Information Product name:Bevacizumab Avastin Purity:98% min CAS NO:216974-75-3 Solubility:Soluble in DMSO Molecular Formula:C6638H10160N1720O2108S44 Package:Package according to customer requirements Molecular Weight:149196.82 Storage:Store at -20℃ Quality control COA Remarks Description: Bevacizumab, a humanized monoclonal antibody, specifically binds to all VEGF-A isoforms with high affinity. IC50 & Target:
Cas 943609-66-3 Vedolizumab Monoclonal Antibodies For Cancer Treatment
Cas 943609-66-3 Vedolizumab Monoclonal Antibodies For Cancer Treatment Chemical Information Product name:Vedolizumab Purity:99% min CAS NO:943609-66-3 Solubility: Molecular Formula:C6528H10072N1732O2042S42 Package:Package according to customer requirements Molecular Weight:146.8 kg/mol Storage:Store at -20℃ Remarks Vedolizumab is a monoclonal antibody developed by Millennium Pharmaceuticals, Inc (a subsidiary of Takeda Pharmaceuticals) for the treatment of ulcerative colitis
Cas 1245916-14-6 Alirocumab Monoclonal Antibodies In Cancer Therapy
Cas 1245916-14-6 Alirocumab Monoclonal Antibodies In Cancer Therapy Chemical Information Product name:Alirocumab Purity:99% min CAS NO:1245916-14-6 Solubility:Soluble in DMSO Molecular Formula:C6472H9996N1736O2032S42 Package:Package according to customer requirements. Molecular Weight:146.0 kg/mol Storage:Store at -20℃ Quality control COA Remarks Alirocumab is a biopharmaceutical drug approved by the FDA on July 24, 2015 as a second line treatment for high cholesterol for
IgG1κ monoclonal antibodies Secukinumab Cas 1229022-83-6
IgG1κ monoclonal antibodies Secukinumab Cas 1229022-83-6 Chemical Information Product name:Secukinumab Purity:95% min CAS NO:1229022-83-6 Solubility:Soluble in DMSO Molecular Formula:C6584H10134N1754O2042S44 Package:Package according to customer requirements. Molecular Weight:147.94 kg/mol g/mol Storage:Store at -20℃ Quality control COA Remarks Secukinumab, is a human IgG1κ monoclonal antibody that binds to the protein interleukin (IL)-17A, and is marketed by Novartis for the
Dulaglutide Cas 923950-08-7 Monoclonal Antibody Glp 1 Inhibitors
Dulaglutide Cas 923950-08-7 Monoclonal Antibody Glp 1 Inhibitors Chemical Information Product name:Dulaglutide Purity:95% min CAS NO:923950-08-7 Solubility:Soluble in DMSO Molecular Formula:C2646H4044N704O836S18 Package:Package according to customer requirements Molecular Weight:59669.81 g/mol Storage:Store at -20℃ Quality control COA Remarks Dulaglutide is a glucagon-like peptide 1 receptor agonist (GLP-1 agonist) consisting of GLP-1(7-37) covalently linked to an Fc fragment
Cas 477202-00-9 Monoclonal Antibody Ipilimumab Breast Cancer
Cas 477202-00-9 Monoclonal Antibody Ipilimumab Breast Cancer Chemical Information Product name:Ipilimumab Purity:95% min CAS NO:477202-00-9 Solubility:Soluble in DMSO Molecular Formula:C6742H9972N1732O2004S40 Package:Package according to customer requirements Molecular Weight:148634.914 g/mol Storage:Store at -20℃ Quality control COA Remarks Ipilimumab is a monoclonal antibody that works to activate the immune system by targeting CTLA-4, a protein receptor that downregulates
Treat Cancer Monoclonal Antibody Nivolumab Cas 242138-07-4
Treat Cancer Monoclonal Antibody Nivolumab Cas 242138-07-4 Chemical Information Product name:Nivolumab Purity:99% min CAS NO:946414-94-4 Solubility:Soluble in DMSO Molecular Formula:C6362H9862N1712O1995S42 Package:Package according to customer requirements Molecular Weight:143.6 kg/mol Storage:Store at -20℃ Quality control COA Remarks Nivolumab is a medication used to treat cancer. It is used as a first line treatment for inoperable or metastatic melanoma in combination with
EGFR inhibitor Monoclonal Antibody Cetuximab Cas 205923-56-4
EGFR inhibitor Monoclonal Antibody Cetuximab Cas 205923-56-4 Chemical Information Product name:Cetuximab Purity:98% min CAS NO:205923-56-4 Solubility:Soluble in DMSO Molecular Formula:C6484H10042N1732O2023S36 Package:Package according to customer requirements Molecular Weight:145781.6 g/mol Storage:Store at -20℃ Quality control COA Remarks Cetuximab is an epidermal growth factor receptor (EGFR) inhibitor used for the treatment of metastatic colorectal cancer, metastatic non
Breast Cancer Monoclonal Antibody Trastuzumab Cas 180288-69-1
Breast Cancer Monoclonal Antibody Trastuzumab Cas 180288-69-1 Chemical Information Product name:Trastuzumab Purity:99% min CAS NO:180288-69-1 Solubility: Molecular Formula:C6470H10012N1726O2013S42 Package:Package according to customer requirements Molecular Weight: Storage:Store at -20℃ Quality control COA Remarks Trastuzumab, sold under the brandname Herceptin among others, is a monoclonal antibody that interferes with the HER2/neu receptor. Its main use is to treat certain
Denosumab Monoclonal Antibody Cas 615258-40-7
Denosumab Monoclonal Antibody Cas 615258-40-7 Chemical Information Product name:Denosumab Purity:99.0% min CAS NO:615258-40-7 Solubility: Molecular Formula:C6404H9912N1724O2004S50 Package:Package according to customer requirements Molecular Weight:144.7 kg/mol Storage:Store at -20℃ Remarks Denosumab, which was approved in the United States in 2010, is a fully human sequence IgG2 monoclonal antibody that inhibits bone resorption by blocking the activity of receptor activator
Cas 1256937-27-5 Monoclonal Antibody AMG 145 Evolocumab
Cas 1256937-27-5 Monoclonal Antibody AMG 145 Evolocumab Chemical Information Product name:AMG 145 Evolocumab Purity:99% min CAS NO:1256937-27-5 Solubility:Soluble in DMSO Molecular Formula:C6242H9648N1668O1996S56 Package:Package according to customer requirements Molecular Weight: Storage:Store at -20℃ Quality control COA Remarks Evolocumab is a monoclonal antibody designed for the treatment of hyperlipidemia. Evolocumab is a fully human monoclonal antibody that inhibits
IgG1 Monoclonal Antibody Ramucirumab Cas 947687-13-0
IgG1 Monoclonal Antibody Ramucirumab Cas 947687-13-0 Chemical Information Product name:Ramucirumab Purity:95% min CAS NO:947687-13-0 Solubility:Soluble in DMSO Molecular Formula:C6374H9864N1692O1996S46 Package:Package according to customer requirements Molecular Weight:143.6 kg/mol Storage:Store at -20℃ Remarks Ramucirumab is a fully human monoclonal antibody (IgG1). Ramucirumab is a direct VEGFR2 antagonist, that binds with high affinity to the extracellular domain of VEGFR2
Pembrolizumab Monoclonal Antibody
Chemical Information Product name:Pembrolizumab Purity:95% min CAS NO:1374853-91-4 Solubility:Soluble in DMSO Molecular Formula:C6534H10004N1716O2036S46 Package:Package according to customer requirements Molecular Weight:146 kDa Storage:Store at -20℃ Remarks Pembrolizumab is a humanized antibody used in cancer immunotherapy. It is an IgG4 isotype antibody that blocks a protective mechanism of cancer cells, and allows the immune system to destroy those cancer cells. It targets
Adalimumab Monoclonal Antibody
Chemical Information Product name:Adalimumab Purity:95% min CAS NO:331731-18-1 Solubility:Soluble in DMSO Molecular Formula:C6428H9912N1694O1987S46 Package:Package according to customer requirements Molecular Weight:144190.30 Storage:Store at -20℃ Quality control COA Remarks Adalimumab is a TNF-inhibiting, anti-inflammatory, biologic medication. It binds to tumor necrosis factor-alpha (TNFα), which normally binds to TNFα receptors, leading to the inflammatory response of
Cd38 Daratumumab Monoclonal Antibody
Chemical Information Product name:Daratumumab Purity:95% min CAS NO:945721-28-8 Solubility:Soluble in DMSO Molecular Formula:C6466H9996N1724O2010S42 Package:Package according to customer requirements Molecular Weight:145,391.67 g/mol Storage:Store at -20℃ Quality control COA Remarks Daratumumab (trade name Darzalex) is an anti-cancer drug. It binds to CD38,which multiple myeloma cells overexpress.Daratumumab was originally developed by Genmab, but it is now being jointly